King Luther Capital Management Corp Purchases New Stake in Avantor, Inc. (NYSE:AVTR)

King Luther Capital Management Corp acquired a new position in Avantor, Inc. (NYSE:AVTR) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 8,000 shares of the company’s stock, valued at approximately $207,000.

A number of other institutional investors have also recently bought and sold shares of AVTR. First Horizon Advisors Inc. lifted its position in shares of Avantor by 30.8% in the third quarter. First Horizon Advisors Inc. now owns 5,629 shares of the company’s stock worth $146,000 after purchasing an additional 1,326 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its stake in Avantor by 1,802.6% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 532,365 shares of the company’s stock valued at $13,772,000 after buying an additional 504,384 shares during the period. PNC Financial Services Group Inc. lifted its position in Avantor by 16.2% in the 3rd quarter. PNC Financial Services Group Inc. now owns 47,732 shares of the company’s stock worth $1,235,000 after buying an additional 6,668 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Avantor during the 3rd quarter valued at $3,282,000. Finally, Banque Cantonale Vaudoise grew its holdings in shares of Avantor by 66.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 109,777 shares of the company’s stock valued at $2,840,000 after acquiring an additional 43,970 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.50% of the stock is owned by corporate insiders.

Avantor Stock Up 2.1 %

AVTR stock opened at $20.78 on Monday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company has a 50-day moving average of $23.89 and a two-hundred day moving average of $23.85. The stock has a market capitalization of $14.14 billion, a price-to-earnings ratio of 45.17, a price-to-earnings-growth ratio of 2.47 and a beta of 1.35. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00.

Analysts Set New Price Targets

A number of research firms recently issued reports on AVTR. Barclays reduced their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. TD Cowen boosted their price target on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Morgan Stanley increased their price objective on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, Wells Fargo & Company dropped their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.